PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29953987-4	2018	In this study, we report whether Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) enhanced etoposide-induced cytotoxicity in NSCLC cells through modulating the XPC expression.	Etoposide	106-115	heat shock protein 90 alpha family class A member 1	Homo sapiens	33-38	
16385570-7	2006	The Hsp90 inhibitors geldanamycin, 17-AAG (17-allylamino-17-demethoxygeldanamycin) and radicicol significantly enhanced the activity of the topoisomerase II poisons etoposide and mitoxantrone in vitro and in vivo.	Etoposide	165-174	heat shock protein 90 alpha family class A member 1	Homo sapiens	4-9	
29953987-8	2018	Hsp90 inhibitor 17-AAG enhanced cytotoxicity and cell growth inhibition of etoposide in NSCLC cells, which were associated with the downregulation of XPC expression and inactivation of AKT.	Etoposide	75-84	heat shock protein 90 alpha family class A member 1	Homo sapiens	0-5	
29953987-9	2018	Our findings suggested that the Hsp90 inhibition induced XPC downregulation involved in enhancing the etoposide-induced cytotoxicity in H1703 and H520 cells.	Etoposide	102-111	heat shock protein 90 alpha family class A member 1	Homo sapiens	32-37	
22053010-9	2012	Moreover, the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) could decrease the etoposide-induced p38 MAPK-mediated ERCC1 expression and augment the cytotoxic effect and growth inhibition by etopsoside.	Etoposide	97-106	heat shock protein 90 alpha family class A member 1	Homo sapiens	14-19